Notably, the persistent and aberrant activation of Nrf2, which is a frequent occurrence in many tumors, provides cancer cells with a selective advantage, leading to tumor progression, metastasis, therapy resistance, and poor prognosis 14, 15. The gene discussed is NFE2L2; the disease is cancer.